XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Interview with Michel Sidibé who became the Director of UNAIDS in 2009. Here he talks about the importance of the international AIDS conferences for bringing in a human rights perspective on the global HIV/AIDS movement.

XVII International AIDS Conference in Mexico City. Interview with Dr Mervyn Silverman from San Francisco, who has been active in the AIDS movement since the early 80's. Here he reflects on the leadership of UNAIDS Director Peter Piot.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.